Creating Hope Reauthorization Act of 2024
United States118th CongressHR-7384House of Representatives
Updated: Feb 16, 2024
Summary
Creating Hope Reauthorization Act of 2024 This bill extends until FY2029 a Food and Drug Administration program that awards priority review vouchers to manufacturers of drugs that treat rare pediatric diseases. (A priority review voucher entitles the voucher holder to priority review of a single human drug application.)
Bill texts
All available records shown.
Timeline
Referred to the House Committee on Energy and Commerce.
House of Representatives
Introduced in House
Referred to the Subcommittee on Health.
House of Representatives
All available records shown.